BACK

ORDER


References www.AlzheimersTreatments.com

  1. Schreursa BG, Bahro M, Molchan SE, Sunderland T, McIntosh AR. Interactions of prefrontal cortex during eyeblink conditioning as a function of age. Neurobiol Aging 2001 Mar;22(2):237-46.
  2. Nadel L, Moscovitch M. Memory consolidation, retrograde amnesia and the hippocampal complex. Curr Opin Neurobiol 1997 Apr;7(2):217-27.
  3. Woodruff-Pak DS, Vogel RW, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci USA 2001 Feb 13;98(4):2089-94.
  4. Plaitakis A, Duvoisin RC. Homer’s moly identified as Galanthus nivalis L.: physiologic antidote to stramonium poisoning. Clin Neuropharmacol 1983 Mar;6(1):1-5.
  5. Woodruff-Pak DS, Santos IS. Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer’s disease. Behav Brain Res 2000 Aug;113(1-2):11-9.
  6. Maelicke A. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer’s disease. Dement Geriatr Cogn Disord 2000 Sep;11 Suppl 1:11-8.
  7. Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk G. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience 2000;99(1):17-23.

BACK

ORDER